Pyrimido [5, 4-b] methotrexate compound and optical isomer, preparation method and application thereof
A technology for optical isomers and compounds, which is applied in the fields of pyrimido[5,4-b]pyrine compounds, optical isomers, preparations and uses thereof, can solve the problems of large toxic and side effects, unsatisfactory oral bioavailability, Lack of irreversible activity of off-target kinases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation Embodiment 1
[0122] Synthesis of Preparation Example 1 S17016
[0123] 1. Synthesis of Intermediate 3
[0124]
[0125] Add 4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine (raw material 2, 17.28g, 1eq) and anhydrous potassium carbonate (2eq) into a 250mL round bottom flask, and dry in vacuo to remove water. Add dry DMF as solvent, crushed (S)-methanesulfonic acid 2-((tert-butoxycarbonyl)amino)-but-3-en-1-yl ester (raw material 1, 24.6g, 1.5eq), Replace nitrogen. Heat and stir at 55° C. for 12 hours, and the time may be extended appropriately to ensure the completion of the reaction.
[0126] After the reaction was completed, water and ethyl acetate were added to extract three times, and the ester layers were combined, back-extracted once with water, and washed with saturated brine. Dry over anhydrous sodium sulfate. Dry column (eluent: CHCl 3 : MeOH=100:1) to get product (S)-(1-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)but-3-ene-2- base) tert-butyl carbamate (Intermediate 3, 19...
experiment Embodiment 1
[0150] Experimental Example 1: Evaluation of Bruton Kinase (BTK) Molecular Level Enzyme Activity Inhibitory Activity
[0151] The enzyme reaction substrate Poly(Glu,Tyr) 4:1 Dilute with PBS without potassium ions (10mM sodium phosphate buffer, 150 mMNaCl, pH 7.2-7.4) to 20μg / mL to coat the microtiter plate, react at 37℃ for 12-16 hours, then use 200μL / well T- Wash the plate three times with PBS (PBS containing 0.1% Tween-20), and dry the microplate in an oven at 37°C for 1-2 hours. In the above substrate-coated ELISA plate, first add the reaction buffer (50mM HEPES pH 7.4, 50mM MgCl 2 , 0.5mM MnCl 2 , 0.2mM Na 3 VO 4 , 1 mM DTT) diluted ATP solution 49 μL / well (final concentration 5 μM). Add 1 μL of the compound to be tested (compound well) or DMSO containing the corresponding concentration (negative control well) to each well, and set no enzyme control well for each experiment. Add 50 μL of BTK tyrosine kinase protein diluted in reaction buffer to start the reaction.
...
experiment Embodiment 2
[0160] Experimental Example 2: Detection of in vitro proliferation inhibitory activity of compounds on human B lymphoma cells Ramos (Burkitt lymphoma) and human diffuse large B lymphoma cells TMD8
[0161] The cell suspension (Ramos: 10,000 cells / well; TMD8: 12,000 cells / well) was inoculated in a 96-well plate, and left in a 37°C incubator for 2 hours until the cell state was stable, and each well was added with different concentrations of the test compound (Three replicate wells are set for each concentration), and a blank control (well containing only culture medium, no cells), a negative control (wells only added cells, no compound) and a positive compound control are set at the same time. After 72 hours of drug treatment, add 20 μL of MTT (5 mg / mL) to each well and incubate at 37°C for 4 hours, add 100 μL of triple solution (10% SDS, 5% isobutanol, 0.01M HCl), and place overnight at 37°C. The OD value was measured at a wavelength of 570nm with an adjustable wavelength micr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com